Sep 16, 2025 02:00AM
Oct 7, 2024 06:00PM
Oct 4, 2024 12:30PM
May 30, 2024 09:00AM
May 7, 2024 04:00PM
Feb 12, 2024 10:54PM
Aug 28, 2023 08:30AM CSL Seqirus Announces Third U.S. Government Award in Relation to Influenza A(H5N8) Candidate Vaccine
Dec 14, 2022 01:00AM
Oct 20, 2022 01:00AM
Oct 12, 2022 01:00AM
Aug 2, 2022 01:00AM
Jul 13, 2022 01:00AM
May 12, 2022 09:21AM
Mar 28, 2022 01:00AM Publication of definitive end result for Vifor Pharma tender offer
Mar 23, 2022 02:00AM
Mar 8, 2022 01:00AM
Mar 3, 2022 01:00AM
Jan 18, 2022 01:08AM
Jan 18, 2022 01:05AM
Dec 14, 2021 01:59AM
Dec 14, 2021 12:44AM CSL Limited announces tender offer to acquire Vifor Pharma Ltd
May 6, 2021 07:05AM
Oct 20, 2020 08:00AM
Jun 24, 2020 06:28PM
Jun 24, 2020 04:07PM
Jun 24, 2020 04:05PM
Jun 8, 2020 04:00PM
Apr 6, 2020 06:45AM Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy
Apr 6, 2020 06:45AM
Feb 3, 2020 08:30AM
Dec 9, 2019 09:00AM
Sep 26, 2019 10:55AM
Aug 31, 2019 08:30AM
Aug 30, 2019 08:30AM
Aug 22, 2019 08:30AM Seqirus to Present Data on Pandemic and Seasonal Influenza Vaccines at OPTIONS X Conference
Jul 17, 2019 08:30AM
Jul 15, 2019 08:30AM
Apr 15, 2019 08:30AM
Nov 16, 2018 09:00AM
Nov 16, 2018 08:00AM
Oct 23, 2018 08:01AM
Oct 3, 2018 05:02PM Seqirus Presents Data at IDWeek Demonstrating Cell-Derived Viruses Have a Closer Match to Circulating Influenza Viruses Compared to Egg-derived Viruses Used in the Production of Influenza Vaccines
Oct 3, 2018 04:45PM
Sep 12, 2018 08:00AM
Aug 23, 2018 09:23AM
Aug 8, 2018 09:57AM
Apr 19, 2018 02:02PM
Mar 13, 2018 11:43AM
Dec 5, 2017 08:39AM CSL and Vitaeris Announce Strategic Partnership with Option to Acquire
Dec 4, 2017 09:08AM

1,157,214 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All